KMTS - CIK 0001877184
The table below shows KESTRA MEDICAL TECHNOLOGIES, LTD.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Cash & equivalents | $291.32M | $175.42M | $201.21M |
| Short-term investments | - | - | - |
| Receivables | - | - | - |
| Inventory | - | - | - |
| Total current assets | $314.06M | $195.41M | $220.69M |
| Property, plant & equipment | $53.80M | $45.93M | $40.38M |
| Goodwill | - | - | - |
| Total assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $379.34M |
| $246.70M |
| $266.30M |
| Accounts payable | $24.02M | $20.21M | $18.57M |
| Total current liabilities | $42.93M | $35.76M | $32.26M |
| Long-term debt | $42.26M | $41.87M | $41.49M |
| Total liabilities | $91.35M | $82.62M | $82.14M |
| Retained earnings | -$613.03M | -$578.86M | -$546.08M |
| Total equity | - | - | - |